Research programme: human monoclonal antibodies - Pamlico Biopharma

Drug Profile

Research programme: human monoclonal antibodies - Pamlico Biopharma

Alternative Names: IgG monoclonal antibodies - Pamlico

Latest Information Update: 21 Feb 2014

Price : $50

At a glance

  • Originator Pamlico Biopharma
  • Developer Cytovance Biologics
  • Class Monoclonal antibodies
  • Mechanism of Action IgG receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Community-acquired pneumonia

Most Recent Events

  • 21 Feb 2014 Preclinical trials in Community-acquired pneumonia in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top